Home › Companies › Artificial Intelligence (AI), Intelligent Systems, Predictive Analytics › NeuroDigm
NeuroDigm
NeuroDigm Co. is a gentle percutaneous procedure with a biocompatible gel to gradually over time create chronic neuropathic pain.
NeuroDigm is active in the artificial intelligence (ai), intelligent systems, predictive analytics space based in Western US, founded in 2016.
Its activity falls under artificial intelligence (ai), intelligent systems, predictive analytics; the profile below is assembled from public directory data.
The business is associated with Western US.
Its current recorded stage is Series_A.
The company reports a headcount in the c_00101_00250 range.
Total disclosed funding stands at about $2.1B.
| Sector | Artificial Intelligence (AI), Intelligent Systems, Predictive Analytics |
|---|---|
| Headquarters | Western US |
| Founded | 2016 |
| Employees | c_00101_00250 |
| Stage | series_a |
| Total funding | $2,100,000,000 |
Website: neurodigm.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account